FCM
CBIO

Farallon Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Farallon Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,500
Closed -$4.06M – 97
2018
Q1 		$4.06M Buy
+2,500
New +$4.06M 0.03% 81